COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?

Circ Res. 2006 Jun 9;98(11):1344-6. doi: 10.1161/01.RES.0000228471.38761.93.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cyclooxygenase 2 / physiology*
  • Cyclooxygenase Inhibitors / pharmacology*
  • Endothelin-1 / chemistry
  • Endothelin-1 / pharmacology
  • Endothelins / physiology*
  • Humans
  • Nitric Oxide / deficiency
  • Nitric Oxide / physiology*
  • Peptide Fragments / pharmacology
  • Receptor, Endothelin A / agonists
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology

Substances

  • Cyclooxygenase Inhibitors
  • Endothelin-1
  • Endothelins
  • Peptide Fragments
  • Receptor, Endothelin A
  • Nitric Oxide
  • Cyclooxygenase 2